Recce Pharmaceuticals Ltd.ASX: RCE

Correction to Appendix 4C and Quarterly Activities Report

· Issued by Recce Pharmaceuticals Ltd.

Filed with ASX · · 7 pages · English

Summary by 6ix AI

The correction clarifies that there were net cash inflows from operating activities, contrary to the previous statement of outflows. Additionally, the cash balance at the end of the quarter has been updated to reflect a higher amount than previously reported.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Recce Pharmaceuticals Ltd. on 6ix

Story so far

Earlier from Recce Pharmaceuticals

Later from Recce Pharmaceuticals

All Recce Pharmaceuticals news releases